See the DrugPatentWatch profile for lipitor

The combination of Lipitor (atorvastatin) and omega-3 fatty acids is a common treatment for high cholesterol and cardiovascular disease. However, whether a prescription is needed for this combination depends on various factors.

According to the FDA-approved label for Lipitor, atorvastatin is a prescription-only medication that requires a doctor's prescription to obtain. [1] Similarly, omega-3 fatty acids, particularly those in the form of prescription-strength supplements, may also require a prescription from a healthcare provider.

However, it's worth noting that over-the-counter (OTC) omega-3 supplements are widely available and do not require a prescription. These supplements typically contain a combination of EPA and DHA, the two primary omega-3 fatty acids found in fish oil. [2]

In some cases, a healthcare provider may prescribe a combination of Lipitor and omega-3 supplements for patients with high cholesterol or cardiovascular disease. This may be particularly true for patients who require a higher dose of omega-3 fatty acids or those who have not responded to OTC supplements.

In terms of the patent status of Lipitor and omega-3 supplements, DrugPatentWatch.com reports that the patent for Lipitor expired in 2011, making it available as a generic medication. [3] However, the patent status of specific omega-3 supplements may vary depending on the manufacturer and formulation.

In conclusion, while OTC omega-3 supplements do not require a prescription, a prescription may be necessary for prescription-strength omega-3 supplements or for patients who require a higher dose or specific formulation. Additionally, a doctor's prescription is always required for Lipitor, as it is a prescription-only medication.

Sources:

[1] FDA. (2020). Lipitor (atorvastatin) label. Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020683s034lbl.pdf>

[2] Omega-3 Information Center. (n.d.). Omega-3 fatty acids. Retrieved from <https://omega-3.com/omega-3-fatty-acids/>

[3] DrugPatentWatch.com. (n.d.). Lipitor (atorvastatin) patent status. Retrieved from <https://www.drugpatentwatch.com/patent/US-5,877,189>